Screener
Haemonetics HAE Europe — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's europe — revenue?
- Haemonetics (HAE) reported europe — revenue of $45.53M in Q2 2026.
- How has Haemonetics's europe — revenue changed year-over-year?
- Haemonetics's europe — revenue increased by 11.4% year-over-year, from $40.88M to $45.53M.
- What does europe — revenue mean?
- Represents the gross revenue recognized from customer contracts in the European region, specifically excluding any sales-based taxes collected on behalf of government authorities. This metric provides a standardized view of core operational sales performance by isolating revenue from tax-related distortions. It is essential for analyzing underlying pricing power and volume growth across the European customer base.
Ask your AI about Haemonetics's europe — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude